Advertisement.

GNWSF Projected Dividend Yield

Stagezero Life Sciences Ltd ( OTCBB : GNWSF )

Stagezero Life Sciences is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. Co. has been granted two foundational U.S. patents for its core platform technology, the Sentinel Principle®, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. Co. is applying the Sentinel Principle® in areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. Co.'s product include ColonSentry™, a blood-based test to assess an individual's current risk for colorectal cancer.

20 YEAR PERFORMANCE RESULTS

GNWSF Dividend History Detail
GNWSF Dividend News
GNWSF Competitors News

# of Shares: 0

Closing Price: 0.36

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000